Non-hormonal steroid modulators of NF-κB for treatment of disease
AssigneeValidus Biopharma Inc.
InventorsJohn M. McCall, Eric Hoffman, Kanneboyina Nagaraju
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-κB for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Claims2
A method of reducing the symptoms of arthritis comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula:
A method of treating arthritis comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula:
Dependencies are inferred from the claim text.